You are here

CDUHR Weekly Update - September 23, 2019


AIDS Seminar
HCV/HIV prevalence, risk, and care among persons who inject drugs in upstate New York
Eli Rosenberg, PhD - SUNY University at Albany
Tuesday, October 8, 10:30-11:30am
715 Broadway, Floor 12, Room 1221
Find more information HERE


Montefiore & Einstein Opioid Conference
On the Front Lines of the Opioid Epidemic
Panelists include: Michael Botticelli, MEd; Mary Jeanne Kreek, MD; Hillary Kunins, MD, MPH, MS; Marc Gourevitch, MD, MPH
September 24, 8:00am-5:00pm
Space is limited
Find more information and register HERE

Drug Researchers’ Roundtable
Misdemeanorland: Social Control in an Age of Broken Windows Policing
Issa Kohler-Hausmann, PhD, JD - Yale University
Thursday, September 26, 4:30-6:00pm
Drug Policy Alliance, 131 West 33rd St, 15th Floor
Find more information and register HERE

Youth Prevention Research Working Group Webinar
Exploring and Disrupting Pathways to Risky Behaviors
Diana H. Fishbein, PhD - Penn State & Kevin P. Haggerty, MSW, PhD - Univ of Washington
Wednesday, October 16, 1:00-2:00pm
Find more information and register HERE

Health Disparities Symposium
Thursday, October 24, 8:00am-5:15pm
550 First Avenue, Farkas Auditorium
Find more information and register HERE

Special HIV Center Rounds
Staying at Zero: The Role of Social Science in Ending the HIV Epidemic
Judith Auerbach, PhD - UCSF
Thursday, October 24, 9:30am-1:00pm
The presentation will be followed by a panel of experts moderated by Dr. Quarraisha Abdool Karim. Breakfast will be served and RSVP requested.
Find more information HERE


Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01)
This FOA solicits research projects that seek to model the underlying mechanisms, processes, and trajectories of social relationships and how these factors affect outcomes in health, illness, recovery, and overall wellbeing.
(Clinical Trials Not Allowed)
(Basic Experimental Studies with Humans Required)

Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
This FOA invites applications for infrastructure support to advance the development of efficacy and/or effectiveness research on recovery support services for those who were or who are being maintained on medications for the treatment of opioid use disorder. The infrastructure support will facilitate multi-stakeholder (e.g. researchers and students, payors, providers, individuals in recovery) research networks through meetings, conferences, small-scale pilots, data development work, short-term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and to build resources for advancing recovery support services research.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
The purpose of this FOA is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics.

Notice of Intent to Publish a Funding Opportunity Announcement for Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 - Clinical Trial Not Allowed)
NIDA intends to publish a FOA to establish 50 new awards for the “Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research” program to provide short-term funding to conduct experiments aiming to expand the range of drug targets and mechanisms for SUD therapies.

NIH Loan Repayment Program
The NIH Loan Repayment Programs (LRPs) are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract that financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research. Research funding from NIH is not required to participate.


Des Jarlais DC, Arasteh K, McKnight C, Feelemyer J, Perlman DC, & Tross S (2019) Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018. Drug and Alcohol Dependence, 204, 107459. Find the abstract on the publisher's website HERE.

Des Jarlais DC, McKnight C, Arasteh K, Feelemyer J, Ross Z, & Cooper HLF (2019) Geographic distribution of risk ("hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history. Harm Reduction Journal, 16, 53. Find the full, open access article on the publisher's website HERE.

Palamar JJ, Le A, Acosta P, & Cleland CM (2019) Consistency of self‐reported drug use among electronic dance music party attendees. Drug and Alcohol Review, doi: 10.1111/dar.12982. Find the abstract on the publisher's website HERE.

Scott E, McComb B, Trachtman H, Mannon L, Rosenfeld P, Thornton R, Bougrab N, Sherman S, & Langford A (2019) Knowledge and use of recruitment support tools among study coordinators at an academic medical center: the novel approaches to recruitment planning study. Contemporary Clinical Trials Communications, 15, 100424. Find the abstract on PubMed HERE.

Tofighi B, Isaacs N, Byrnes-Enoch H, Lakew R, Lee JD, Berry C, & Schatz D (2019) Expanding treatment for opioid use disorder in publicly funded primary care clinics: exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program. Journal of Substance Abuse Treatment, doi: 10.1016/j.jsat.2019.08.003. Find the abstract on the publisher's website HERE.


American Public Health Association Annual Meeting
Creating the Healthiest Nation: For Science. For Action. For Health
November 2-6 - Philadelphia, PA

Community Reclaiming the Global Response
July 5-7, 2020 - Mexico City, Mexico


The K12 Career Development Program in Substance Use and Addiction Medicine, based at Massachusetts General Hospital is recruiting post-doctoral clinician-scientists. It aims to provide scholars with a concentrated research experience, mentorship, and advanced training to prepare them for leadership in addiction medicine through independent research careers in academics or industry or influential positions in government. Eligible applicants will have completed doctoral-level training in a clinical discipline (MD, PhD or equivalent). Find the full announcement HERE.